Medications

FDA approves Litfulo for teens, adults with alopecia areata

The U.S. Food and Drug Administration has approved Litfulo (ritlecitinib) for adults and adolescents aged 12 years and older with severe alopecia areata at a recommended dose of 50 mg. Approval of Litfulo was granted to Pfizer.

Gastroenterology

First pill for fecal transplants wins FDA approval

U.S. health officials on Wednesday approved the first pill made from healthy bacteria found in human waste to fight dangerous gut infections—an easier way of performing so-called fecal transplants.

page 6 from 28